Mesoblast MESO
NASDAQ MESO
$14.80 -0.07 (-0.47%)
As of: Sep 30, 2026 · 10:11 AM EDT

Mesoblast (MESO) Other Working Capital Changes (2019 - 2020)

Updated

Mesoblast (MESO) posted Other Working Capital Changes of -$524,000 for the quarter ended Mar 31, 2020.

Analysis

Mesoblast (MESO) Other Working Capital Changes (2019 - 2020) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn
10 Mesoblast 1.88 Bn 1.44 Bn -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2020 -524,000.00
Dec 31, 2019 -360,000.00
Sep 30, 2019 -335,000.00
API Access

Mesoblast Other Working Capital Changes API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-working-capital-changes&ticker=MESO&period=max&api_key=YOUR_API_KEY